小肠原发性血管肉瘤一例并文献复习
Primary Angiosarcoma of the Small Intestine: A Case Report and Literature Review
DOI: 10.12677/ACM.2022.121102, PDF,    国家自然科学基金支持
作者: 潘 越, 周 璇, 赵 涵, 赵 鹏*:青岛大学附属医院病理科,山东 青岛
关键词: 小肠血管肉瘤组织学特征免疫组化鉴别诊断Small Intestine Angiosarcoma Histological Features Immunohistochemistry Differential Diagnosis
摘要: 目的:探讨小肠原发性血管肉瘤的组织学特征、免疫组化特征、鉴别诊断和治疗方法。方法:回顾性分析1例小肠原发性血管肉瘤患者的临床资料、组织学诊断及免疫组化结果,并对相关文献进行复习。结果:患者,男,67岁,镜下观察肿瘤由实体性区域和出血坏死区域构成。肿瘤细胞异型性明显,细胞核大呈圆形、多形性,空泡样,具有多形性、间变性特点,核仁大而明显,核分裂象易见,约10个/10HPF;部分细胞胞质丰富,呈嗜双色性。免疫组化显示肿瘤细胞表达CD31、ERG及Fli-1,部分表达CD34。小肠血管肉瘤组织学特征有时可能与其他发生于小肠的肿瘤相混淆,需要与多种肿瘤相鉴别。小肠的血管肉瘤预后较其他部位的血管肉瘤差,本病例患者于术后10个月因全身多脏器转移而死亡。手术切除加术后化疗或姑息性化疗是小肠血管肉瘤的主要治疗方式。结论:小肠原发性血管肉瘤是一种罕见恶性肿瘤,预后差,临床症状无特异性,极易误诊或延迟诊断,因此经常被误诊为其他胃肠道常见病,病理医生需掌握其组织学、免疫组织化学特点及鉴别诊断要点,从而做出准确诊断。
Abstract: Objective: To investigate the histological and immunohistochemical features, differential diagnosis and treatment of primary angiosarcoma of small intestine. Methods: We retrospectively analyzed the clinical data, histological diagnosis and immunohistochemical results of one patient with primary hemangiosarcoma of the small intestine and reviewed relevant literatures. Results: The patient, male, 67 years old. Microscopically, the tumor consisted of solid areas and areas of hemorrhage and necrosis. The tumor cells showed obvious atypia, with large round, pleomorphic and vacuolated nuclei, pleomorphic and anaplastic. The nucleoli were large and obvious, and the mitotic figures were about 10/10HPF. Some cells are rich in cytoplasm, showing dichroism. Immunohistochemistry showed that the tumor cells expressed CD31, ERG and Fli-1, and partially expressed CD34. The histological features of small intestinal angiosarcoma may sometimes be confused with other tumors of the small intestine and need to be differentiated from multiple tumors. The prognosis of angiosarcoma in the small intestine is worse than that in other sites. The patient died 10 months after surgery due to systemic multiple organ metastases. Surgical resection combined with postoperative chemotherapy or palliative chemotherapy has been the main treatment for small intestinal angiosarcoma. Conclusion: Primary angiosarcoma of the small intestine is a rare malignant tumor with poor prognosis and no specific clinical symptoms. It is easy to be misdiagnosed or delayed diagnosis. Therefore, it is often misdiagnosed as other common diseases of the gastrointestinal tract. Pathologists should master the histological and immunohistochemical characteristics and key points of differential diagnosis so as to make a definite diagnosis.
文章引用:潘越, 周璇, 赵涵, 赵鹏. 小肠原发性血管肉瘤一例并文献复习[J]. 临床医学进展, 2022, 12(1): 694-701. https://doi.org/10.12677/ACM.2022.121102

参考文献

[1] Young, R., Brown, N., Reed, M., Hughes, D. and Woll, P. (2010) Angiosarcoma. The Lancet Oncology, 11, 983-991. [Google Scholar] [CrossRef
[2] 赵志勋, 关旭, 陈瑛罡, 王锡山. 原发性小肠恶性肿瘤诊疗进展[J]. 中华胃肠外科杂志, 2017, 20(1): 117-120.
[3] Shon, W. and Billings, S. (2019) Epithelioid Vascular Tumors: A Review. Advances in Anatomic Pathology, 26, 186-197. [Google Scholar] [CrossRef
[4] Reynolds, I., Healy, P. and Mcnamara, D. (2014) Malignant Tumours of the Small Intestine. Surgeon, 12, 263-270. [Google Scholar] [CrossRef] [PubMed]
[5] Navarro-Chagoya, D., Figueroa-Ruiz, M., López-Gómez, J., Nava-Leyva, H., Álvarez-Ponce, C., Guzmán-Sombrero, G., et al. (2015) Obscure Gastrointestinal Bleeding Due to Multifocal Intestinal Angiosarcoma. International Journal of Surgery Case Reports, 10, 169-172. [Google Scholar] [CrossRef] [PubMed]
[6] Leong, J., Rascon, M. and Kaushik, N. (2008) Multifocal Angiosarcoma of the Gastrointestinal Tract. E252-E253. [Google Scholar] [CrossRef] [PubMed]
[7] Li, R., Ouyang, Z.Y., Xiao, J.B., He, J., Zhou, Y.W., Zhang, G.Y., et al. (2017) Clinical Characteristics and Prognostic Factors of Small Intestine Angiosarcoma: A Retrospective Clinical Analysis of 66 Cases. Cellular Physiology and Biochemistry, 44, 817-827. [Google Scholar] [CrossRef] [PubMed]
[8] Takahashi, M., Ohara, M., Kimura, N., Domen, H., Yamabuki, T., Komuro, K., et al. (2014) Giant Primary Angiosarcoma of the Small Intestine Showing Severe Sepsis. World Journal of Gastroenterology, 20, 16359-16363. [Google Scholar] [CrossRef] [PubMed]
[9] Nai, Q., Ansari, M., Liu, J., Razjouyan, H., Pak, S., Tian, Y., et al. (2018) Primary Small Intestinal Angiosarcoma: Epidemiology, Diagnosis and Treatment. Journal of Clinical Medicine Research, 10, 294-301. [Google Scholar] [CrossRef] [PubMed]
[10] Squillaci, S., Marasco, A., Pizzi, G., Chiarello, M., Brisinda, G. and Tallarigo, F.J.P. (2020) Primary Post-Radiation Angiosarcoma of the Small Bowel. Report of a Case and Review of the Literature. Pathologica, 112, 93-101. [Google Scholar] [CrossRef
[11] Young, R., Fernando, M., Hughes, D., Brown, N. and Woll, P. (2014) Angiogenic Growth Factor Expression in Benign and Malignant Vascular Tumours. Experimental and Molecular Pathology, 97, 148-153. [Google Scholar] [CrossRef] [PubMed]
[12] Bouche, G. andré, N., Banavali, S., Berthold, F., Berruti, A., Bocci, G., et al. (2014) Lessons from the Fourth Metronomic and Anti-Angiogenic Therapy Meeting, 24-25 June 2014, Milan. Ecancermedicalscience, 8, 463.
[13] De Francesco, V., Bellesia, A., Corsi, F., Pennella, A., Ridola, L., Zullo, A., et al. (2015) Multifocal Gastrointestinal Angiosarcoma: A Challenging Diagnosis? The Journal of Gastrointestinal and Liver Diseases, 24, 519-522. [Google Scholar] [CrossRef] [PubMed]
[14] Sullivan, H., Edgar, M., Cohen, C., Kovach, C., HooKim, K. and Reid, M. (2015) The Utility of ERG, CD31 and CD34 in the Cytological Diagnosis of Angiosarcoma: An Analysis of 25 Cases. Journal of Clinical Pathology, 68, 44-50. [Google Scholar] [CrossRef] [PubMed]
[15] Huntington, J., Jones, C., Liebner, D., Chen, J. and Pollock, R. (2015) Angiosarcoma: A Rare Malignancy with Protean Clinical Presentations. Journal of Surgical Oncology, 111, 941-950. [Google Scholar] [CrossRef] [PubMed]
[16] Wang, Q., et al. (2018) Primary Colonic Angiosarcoma Seen in a Patient on Calcium Channel Blocker: A Case Report with Summary Analysis of 32 Other Cases from the Literature. The American Journal of Case Reports, 19, 254-261. [Google Scholar] [CrossRef
[17] Xia, J., Shi, D., Wu, Z., Chen, Y., Liu, B., Chen, L., et al. (2018) The Poor Prognosis of the Primary Gastric Epithelioid Angiosarcoma: A Case Report. Medicine (Baltimore), 97, e0287. [Google Scholar] [CrossRef
[18] Agulnik, M., Yarber, J., Okuno, S., von Mehren, M., Jovanovic, B., Brockstein, B., et al. (2013) An Open-Label, Multicenter, Phase II Study of Bevacizumab for the Treatment of Angiosarcoma and Epithelioid Hemangioendotheliomas. Annals of Oncology, 24, 257-263. [Google Scholar] [CrossRef] [PubMed]
[19] Cuadra-Urteaga, J., Font, A., Tapia, G., Areal, J. and Taron, M. (2016) Carcinosarcoma of the Upper Urinary Tract with an Aggressive Angiosarcoma Component. Cancer Biology & Therapy, 17, 233-236. [Google Scholar] [CrossRef] [PubMed]
[20] Kollár, A., Jones, R., Stacchiotti, S., Gelderblom, H., Guida, M., Grignani, G., et al. (2017) Pazopanib in Advanced Vascular Sarcomas: An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) Retrospective Analysis. Acta Oncologica, 56, 88-92. [Google Scholar] [CrossRef